$27.50-0.63 (-2.24%)
Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. in the Healthcare sector is trading at $27.50 with a market capitalization of $3.0B. Wall Street consensus targets $33.39 (14 analysts), implying a +21.4% move over the next 12 months. The stock is currently 23% below its 52-week high of $35.83, remaining 19.5% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $865.84M↑ | $828.80M↑ | $821.46M↓ | $851.57M↓ | $869.23M |
| Gross Profit | $835.64M↑ | $799.31M↑ | $790.70M↓ | $821.16M↓ | $840.70M |
| Operating Income | $87.77M↑ | $83.84M↑ | $47.64M↓ | $119.52M↓ | $142.30M |
| Net Income | $10.93M↑ | $4.11M↑ | -$1.18B↓ | $36.25M↑ | $30.13M |
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilit...

Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

ACHC's premium valuation faces a key test as facility growth and stronger EBITDA guidance compete with rising costs and weaker returns.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 18.3% over the past six months, topping the S&P 500 by 7.4 percentage points.